Marvin Labs

$CL delivered a 2Q-2026 earnings beat as aggressive margin expansion offset volume weakness in North America. * GAAP EPS decreased 5% to $0.86, but adjusted EPS of $0.99 (+8% YoY) beat the $0.95 expectation. * Net sales of $5.36B (+4.9% YoY) beat the $5.358B expectation. * Adjusted gross margin expanded 140bps YoY to 61.5% as productivity gains helped offset volume pressure. * Updated guidance: FY26 adjusted EPS growth is now mid-single-digits (vs low- to mid-single-digits) and adjusted gross margin is now roughly flat (vs down). Emerging market strength and 15% higher advertising spending are sustaining the company's 41.3% global toothpaste market share. Management is prioritizing premium innovation to offset a 3.9% organic volume decline in North America. Earnings call today at 08:30 am EDT.

Dominion Energy $D delivered a solid 2Q-2026 beat as Virginia regulatory tailwinds offset nuclear fund volatility. * Adjusted EPS of $0.79 beat the $0.73 analyst expectation and grew 5.3% year-over-year. * Revenue reached $4.48B, representing a 20.4% increase year-over-year and exceeding expectations by 9.5%. * Dominion Energy Virginia operating earnings jumped to $0.76 per share, up from $0.64 in 2Q25. Regulatory outcomes from the 2025 Biennial Review and increased rider equity returns in Virginia are now the primary drivers of earnings growth. These tailwinds effectively shielded the bottom line from wider corporate losses and declining results in non-regulated segments. Earnings call today at 11:00 am EDT.

Linde delivers a solid 2Q-2026 beat, powered by a record $8.1B sale of gas backlog despite inflationary headwinds. * Adjusted EPS of $4.50 (+10% YoY) beat the $4.49 consensus expectation. * Sales reached $9.29B (+9% YoY), exceeding the $9.06B expectation on strong APAC and electronics demand. * Adjusted operating margin reached 29.5%, though it compressed 60bps YoY as pricing and productivity gains were offset by cost inflation. * Sale of gas project backlog climbed to a record $8.1B, part of a total $11B project pipeline. Linde is effectively leveraging its contract-based model to secure long-term electronics growth in the U.S. and APAC. While margin compression reflects persistent macro inflation, the expanding high-quality backlog provides a clear runway for the updated FY2026 adjusted EPS guidance of $17.70-$17.90. Earnings call today at 09:00 am EDT.

$MRNA 2Q-2026 results show a focus on expense management as the company improves its cost outlook to mitigate a late-stage pipeline setback for its norovirus candidate. * Revenue of $145M for 2Q-2026 grew 2% year-over-year, supported by United Kingdom deliveries and collaboration revenue that offset lower domestic COVID-19 vaccine sales. * Adjusted loss per share was -$1.97 for 2Q-2026, meeting the analyst expectation of -$1.97 and narrowing from a -$2.13 loss in the same period last year. * Updated 2026 guidance improves the GAAP operating expense outlook by $0.2B and raises the expected year-end cash balance to a range of $4.7B to $5.2B. The norovirus failure at Phase 3 interim analysis delays a key non-respiratory growth driver. This shifts focus to the August 5 PDUFA for mFLUSIVA as the company seeks a fifth product approval to expand its portfolio while reducing its spending. Earnings call today at 08:00 am EDT.

$CVX delivers a blowout 2Q-2026 with adjusted EPS of $6.06, smashing expectations as record production meets a high-price environment. * Adjusted EPS of $6.06 (+242% YoY) beat the $5.57 expectation by $0.49. * Revenue reached $67.2B, up 51% YoY and $6.8B ahead of consensus estimates. * Total production hit a record 4.07M BOED (+20% YoY), driven by the Hess acquisition and Permian growth. * Structural cost reductions reached a $3B annual run-rate six months ahead of the company schedule. The early delivery of $1.5B in Hess synergies and cost targets indicates high execution discipline following the merger. A 20-year power deal with Microsoft for 2.67 gigawatts marks a significant move to monetize West Texas energy assets for AI data centers. Earnings call today at 11:00 am EDT.

$CTVA raises FY26 guidance as margin expansion and Seed technology demand offset a 2Q revenue miss and pricing headwinds in Latin America. * Adjusted EPS of $2.30 in 2Q26 beat the $2.24 expectation, up 5% YoY despite a 1% decline in net sales. * Net sales of $6.38B missed the $6.60B expectation, pressured by a 3% price decline in Crop Protection and volume shifts in Latin America. * Adjusted EBITDA margin expanded 130bps YoY to 35.4% in 2Q26, driven by higher royalty income and cost discipline. * FY26 adjusted EPS guidance raised to $3.60-$3.80 (formerly $3.45-$3.70) ahead of the October 1 Vylor separation. Management is successfully decoupling earnings growth from top-line volatility via operational efficiency and Seed licensing. The guidance raise reflects confidence that the Vylor spin-off will protect earnings despite uneven revenue growth. Earnings call today at 09:00 am EDT.

$AAPL 3Q-2026 revenue surges 16% year-over-year as iPhone sales and one-time tariff benefits drive record results. * Revenue reached $109.4B, beating expectations of $109.0B, led by 22% growth in iPhone sales. * Diluted EPS was $2.02, up 29% year-over-year and ahead of the $1.88 analyst expectation. * Gross margin expanded to 50.1%, including a 200bps favorable impact from tariff refunds. * Services revenue set a record at $30.7B, while Mac revenue jumped 29% year-over-year. The surge in iPhone and Mac revenue, alongside the introduction of Siri AI, indicates strong upgrade demand despite macroeconomic pressures. While tariff refunds inflated the bottom line, broad growth across every geographic segment, including a 22% rebound in Greater China, reinforces $AAPL market leadership. Earnings call today at 05:00 pm EDT.

$FND beat 2Q-2026 expectations as flooring demand showed signs of stabilization with comparable store sales improving sequentially through the quarter. * Adjusted EPS of $0.58 beat the $0.57 expectation, while net sales rose 3.0% to $1,250.3M, exceeding the $1,232M consensus. * Comparable store sales decreased 2.1% year-over-year, but improved from a 5.1% decline in April to nearly flat in June. * Diluted EPS guidance for FY2026 was raised to $2.20-$2.45, reflecting the impact of tariff refunds, while adjusted EPS guidance is $1.88-$2.13. * GAAP gross margin expanded 430bps to 48.2% due to tariff refunds, while adjusted gross margin contracted 20bps to 43.7%. The sequential trend in comparable sales suggests the downturn in discretionary flooring projects may be finding a floor. Continued expansion remains a primary growth lever, with five new stores opened in 2Q and 20 planned for the full year. Earnings call scheduled for today at 05:00 pm EDT.

$SYK 2Q-2026 results show a sharp rebound from its 1Q-2026 cyber incident, topping earnings expectations as adjusted operating margins reached a record 27.4%. * Adjusted EPS of $3.69 increased 17.9% year-over-year and beat the $3.46 expectation by 6.6%. * Net sales grew 9.4% to $6.6B, slightly ahead of the $6.58B expectation, with organic growth at 9.0%. This growth was driven primarily by unit volume increases rather than pricing. * Adjusted operating margin expanded 170bps year-over-year to 27.4%, recovering from the 21.1% seen last quarter during the cyber disruption. * Guidance for full-year 2026 organic sales narrowed to 8.3% - 9.3% with adjusted EPS in the range of $14.95 - $15.10. The performance indicates strong volume recovery in the MedSurg and Orthopaedics segments. Management's updated guidance suggests confidence that the operational momentum regained this quarter will persist through the second half of the year. Earnings call today at 04:30 pm EDT.

AWS revenue growth accelerated for the fifth consecutive quarter, reaching its fastest pace in 18 quarters to define $AMZN 2Q-2026 results. * Net sales of $200.6B increased 20% year-over-year, exceeding the $196.4B market expectation. * AWS revenue surged 37% year-over-year to $42.2B, driven by triple-digit growth in its $25B+ annual run rate AI and chips businesses. * Reported diluted EPS of $5.75 beat the $1.82 expectation, though this includes a $53.4B pre-tax gain from the company's investment in Anthropic. * Free cash flow fell to a $7.6B trailing twelve-month outflow as property and equipment purchases increased by $66.1B year-over-year to support AI infrastructure. Custom silicon and generative AI demand are driving a structural re-acceleration in AWS, justifying the pivot toward heavy capital spending despite the negative impact on trailing twelve-month cash flow. Earnings call today at 05:00 pm EDT.

$SO 2Q-2026 adjusted EPS rose 23% year-over-year to $1.13, beating the $1.01 expectation despite revenue growth of just 0.1% for the period. * Adjusted EPS of $1.13 (+22.8% YoY) exceeded the $1.01 expectation, while 2Q-2026 revenue of $6.98B (+0.1% YoY) fell short of the $7.25B consensus. * Commercial kilowatt-hour sales rose 7.3% (7.4% weather-adjusted) as economic development and data center demand in the Southeast accelerated. * Traditional electric operating companies added $0.20 per share to year-over-year earnings, driven by higher retail sales and improved performance at state-regulated utilities. Strong bottom-line growth resulted from robust utility demand and improved operational performance at state-regulated units. The revenue miss against expectations reflects lower fuel cost recoveries and a mismatch in market volume projections. Earnings call scheduled for today at 01:00 pm EDT.

$MA delivered a double beat in 2Q-2026 as robust cross-border volume and value-added services offset potential macro headwinds. * Adjusted EPS of $5.04 exceeded the $4.77 expectation, representing 21% year-over-year growth. * Net revenue rose 14% to $9.3B, surpassing the $9.08B expectation on network strength. * Adjusted operating margin expanded 120bps to 61.1% from 59.9% in the prior year period. * Cross-border volume grew 12% on a local currency basis, while switched transactions increased 9%. The results demonstrate the scalability of Mastercard's network and the growing contribution of its "Agentic Payment" capabilities. Management returned $5.7B to shareholders through dividends and share repurchases this quarter, highlighting sustained cash flow strength. Earnings call scheduled for today at 09:00 am EDT.

$BMY delivered a significant 2Q-2026 beat-and-raise as its Growth Portfolio surged to 59% of total revenue. * Adjusted EPS of $2.04 (+40% year-over-year) significantly exceeded the $1.59 expectation. * Revenue reached $13.0B (+6% year-over-year), beating the $11.7B expectation on strong $7.6B Growth Portfolio sales. * Management raised 2026 guidance for revenue to $49.0B-$50.0B and adjusted EPS to $6.75-$7.00. * Opdivo Qvantig revenue surged over 200% as the next-generation launch continues to scale. The portfolio transition is reaching a critical inflection point where high-margin Growth Portfolio assets are more than offsetting legacy generic erosion. The significant guidance lift reflects improved operational leverage as the revenue mix shifts toward newer, higher-value launches like Reblozyl and Camzyos. Earnings call today at 08:15 am EDT.

$MO results for 2Q-2026 highlight a significant consumer shift as premium smokers trade down to discount brands in a pressured economic environment. * Adjusted EPS of $1.48 grew 2.8% year-over-year but missed the $1.50 expectation. Revenue net of excise taxes rose 1.2% to $5,356M. * Marlboro retail share dropped 150bps to 39.5% while industry-wide discount share climbed 260bps to 33.8%. * Domestic cigarette volume fell 3.2% overall, though Altria discount brand volume surged 67.3% as Basic gained traction. * Management narrowed full-year 2026 adjusted EPS guidance to $5.61-$5.72, raising the lower end of the previous range. The surge in discount volume suggests Altria is capturing its own departing premium customers, though the shift weighs on segment margins. Expanding the smoke-free portfolio to 120,000 stores provides a necessary long-term hedge against premium volume erosion. Earnings call at 09:00 am EDT today.

$AEP 2Q-2026 earnings show an adjusted EPS miss as prior asset sales weigh on results, yet management is raising full-year guidance. * Adjusted EPS of $1.36 fell 8.7% below expectations and declined 4.9% year-over-year. * Revenue of $5.45B beat expectations by 2.2%, driven by robust utility demand. * Raised FY2026 operating guidance range to $6.25-$6.55 per share. * Expanded new load additions through 2030 to 69 GW, up from 63 GW last quarter. The 2Q earnings contraction stems from the 2025 transmission minority interest sale and tax timing, masking underlying utility growth. Management is aggressively pivoting toward infrastructure to capture massive projected load additions, identifying $16B in residential cost offsets from incoming large-scale customers to support affordability. Earnings call today at 09:00 am EDT.

$APD reports a $2.9B charge to pivot its portfolio in 3Q-2026, yet management raised guidance as the core business outperformed. * Adjusted EPS of $3.47 increased 12% year-over-year, exceeding the $3.36 expectation. * Sales of $3.2B rose 5% year-over-year, missing the $3.20B expectation. * Adjusted operating margins expanded 110bps to 25.6% despite higher costs. * Management raised FY26 adjusted EPS guidance to a range of $13.39 to $13.49. The $2.9B write-down from exiting clean energy projects in Louisiana and Arizona reflects a tactical shift toward capital discipline. By narrowing its focus to high-quality industrial gas and electronics assets, the company is prioritizing margin expansion over long-term project volume. Earnings call today at 08:00 am EDT.

$EXC delivers 2Q-2026 adjusted EPS growth of 10% YoY, navigating higher interest and depreciation through aggressive rate base execution. * Adjusted EPS of $0.43 met analyst expectations, up from $0.39 in 2Q-2025. * Revenue reached $5.97B, a 10% YoY increase that beat the $5.66B analyst expectation by 5.5%. * Higher distribution and transmission rates at ComEd, PHI, and BGE offset headwinds from higher interest expense and credit loss expenses. * BGE filed a $156M electric distribution rate case in Maryland in July to support ongoing grid investments and storm recovery. The results highlight Exelon's reliance on regulatory execution to sustain growth amid rising costs. Operational reliability remains a core driver, with ComEd and PHI achieving top-decile performance while the company moves to capture demand from grid modernization. Earnings call today at 10:00 am EDT.

$REGN shares momentum as 2Q-2026 results crush expectations on record Dupixent and EYLEA HD performance. * Total revenue reached $4.29B (+17% year-over-year), significantly exceeding the $3.83B consensus expectation. * Adjusted EPS of $14.29 (+11% year-over-year) beat the $8.00 expectation, even after a $0.99 negative impact from acquired IPR&D. * Global Dupixent sales surged 38% to a record $6.0B, while U.S. EYLEA HD sales grew 52% to $596M as the transition from the legacy EYLEA product continues. * Full-year 2026 guidance for adjusted gross margin was raised to a range of 84%-85%, up from the prior 83%-84% expectation. The full repayment of the Sanofi Development Balance this quarter eliminates a long-standing obligation and clears the path for a meaningful step-up in collaboration profits starting in 3Q-2026. This financial flexibility, combined with a pipeline of 50 clinical assets, supports the company's aggressive $2.5B remaining share buyback authorization. Earnings call today at 08:30 am EDT.

$CI delivered a beat-and-raise for 2Q-2026 even as pharmacy contract renewals and rising medical costs weighed on margins. * Adjusted EPS of $7.78 grew 8% year-over-year, surpassing the $7.60 expectation. * Total revenue rose 7% to $71.7B, exceeding consensus by $1.5B on strong specialty pharmacy volumes. * The Medical Care Ratio (MCR) increased 130bps to 84.5% due to lower risk adjustment benefits. * Full-year 2026 adjusted EPS guidance was raised by $0.10 to at least $30.45. Strength in the Cigna Healthcare employer business drove a 17% increase in segment income, offsetting a 27% drop in pharmacy benefit earnings following major client renewals. The planned exit from individual medical plans by 2027 signals a strategic pivot toward more predictable commercial segments as the company manages elevated medical cost trends. Earnings call today at 08:30 am EDT.

$TT 2Q-2026 results deliver a record $12.1B backlog despite significant margin compression in EMEA. * Adjusted EPS of $4.31 beat expectations of $4.26, while revenue rose 11% YoY to $6.35B. * Record backlog jumped 70% YoY to $12.1B, supported by 50% bookings growth in Americas Commercial HVAC. * Management raised FY26 adjusted EPS guidance to $15.20-$15.30 following strong enterprise bookings momentum. * Adjusted operating margin contracted 60bps to 19.7% as EMEA adjusted operating margin fell 420bps. The massive backlog expansion provides multi-year visibility, yet the 420bps margin drop in EMEA highlights regional execution risks and transport headwinds. Trane is trading current margin for future volume as sustainability demand outpaces its immediate capacity to scale profitably in Europe. Earnings call today at 10:00 am EDT.